Buddy E. Cantrell

1.1k total citations
28 papers, 966 citations indexed

About

Buddy E. Cantrell is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Buddy E. Cantrell has authored 28 papers receiving a total of 966 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 23 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Buddy E. Cantrell's work include Neuropeptides and Animal Physiology (19 papers), Receptor Mechanisms and Signaling (13 papers) and Pharmacological Receptor Mechanisms and Effects (12 papers). Buddy E. Cantrell is often cited by papers focused on Neuropeptides and Animal Physiology (19 papers), Receptor Mechanisms and Signaling (13 papers) and Pharmacological Receptor Mechanisms and Effects (12 papers). Buddy E. Cantrell collaborates with scholars based in United States. Buddy E. Cantrell's co-authors include Dennis M. Zimmerman, J. David Leander, James B. Thomas, S. Wayne Mascarella, Richard B. Rothman, Christina M. Dersch, Hamideh Zarrinmayeh, Paul L. Ornstein, Thomas C. Britton and Heng Xu and has published in prestigious journals such as Pain, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

Buddy E. Cantrell

27 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Buddy E. Cantrell United States	17	605	527	334	58	51	28	966
Kevin J. Merchant United States	18	599 1.0×	454 0.9×	509 1.5×	90 1.6×	48 0.9×	30	1.3k
Bertrand Le Bourdonnec United States	16	489 0.8×	255 0.5×	511 1.5×	97 1.7×	92 1.8×	38	1.0k
Sham S. Nikam United States	18	339 0.6×	207 0.4×	310 0.9×	75 1.3×	42 0.8×	28	696
Robert W. McNutt United States	18	892 1.5×	867 1.6×	199 0.6×	306 5.3×	44 0.9×	29	1.3k
Robert M. DeMarinis United States	17	452 0.7×	285 0.5×	214 0.6×	102 1.8×	44 0.9×	41	750
Philip J. M. van Galen United States	16	610 1.0×	187 0.4×	400 1.2×	68 1.2×	40 0.8×	21	1.1k
Hartmut E. Greiner Germany	17	394 0.7×	314 0.6×	234 0.7×	89 1.5×	100 2.0×	32	839
Hossein Mazandarani United States	13	293 0.5×	218 0.4×	273 0.8×	19 0.3×	79 1.5×	15	630
Christopher F. Bigge United States	21	478 0.8×	288 0.5×	504 1.5×	37 0.6×	35 0.7×	47	991
Isabelle Berque‐Bestel France	16	437 0.7×	342 0.6×	116 0.3×	55 0.9×	87 1.7×	22	681

Countries citing papers authored by Buddy E. Cantrell

Since Specialization

Citations

This map shows the geographic impact of Buddy E. Cantrell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Buddy E. Cantrell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Buddy E. Cantrell more than expected).

Fields of papers citing papers by Buddy E. Cantrell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Buddy E. Cantrell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Buddy E. Cantrell. The network helps show where Buddy E. Cantrell may publish in the future.

Co-authorship network of co-authors of Buddy E. Cantrell

This figure shows the co-authorship network connecting the top 25 collaborators of Buddy E. Cantrell. A scholar is included among the top collaborators of Buddy E. Cantrell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Buddy E. Cantrell. Buddy E. Cantrell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thomas, James B., Richard B. Rothman, S. Wayne Mascarella, et al.. (2004). Importance of Phenolic Address Groups in Opioid Kappa Receptor Selective Antagonists. Journal of Medicinal Chemistry. 47(4). 1070–1073. 23 indexed citations

Carroll, F. Ivy, Li Zhang, S. Wayne Mascarella, et al.. (2003). Discovery of the First N-Substituted 4β-Methyl-5-(3-hydroxyphenyl)morphan To Possess Highly Potent and Selective Opioid δ Receptor Antagonist Activity. Journal of Medicinal Chemistry. 47(2). 281–284. 13 indexed citations

Thomas, James B., Robert N. Atkinson, S. Wayne Mascarella, et al.. (2003). Identification of (3R)-7-Hydroxy-N-((1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a Novel Potent and Selective Opioid κ Receptor Antagonist. Journal of Medicinal Chemistry. 46(14). 3127–3137. 70 indexed citations

Shepherd, Timothy A., James Aikins, David Bleakman, et al.. (2002). Design and Synthesis of a Novel Series of 1,2-Disubstituted Cyclopentanes as Small, Potent Potentiators of 2-Amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)propanoic Acid (AMPA) Receptors. Journal of Medicinal Chemistry. 45(10). 2101–2111. 29 indexed citations

Thomas, James B., Robert N. Atkinson, Nivedita Namdev, et al.. (2002). Discovery of an Opioid κ Receptor Selective Pure Antagonist from a Library of N-Substituted 4β-Methyl-5-(3-hydroxyphenyl)morphans. Journal of Medicinal Chemistry. 45(16). 3524–3530. 23 indexed citations

Thomas, James B., Robert N. Atkinson, Richard B. Rothman, et al.. (2001). Identification of the First trans-(3R,4R)- Dimethyl-4-(3-hydroxyphenyl)piperidine Derivative To Possess Highly Potent and Selective Opioid κ Receptor Antagonist Activity. Journal of Medicinal Chemistry. 44(17). 2687–2690. 91 indexed citations

Ornstein, Paul L., Dennis M. Zimmerman, M. Brian Arnold, et al.. (2000). Biarylpropylsulfonamides as Novel, Potent Potentiators of 2-Amino-3- (5-methyl-3-hydroxyisoxazol-4-yl)- propanoic Acid (AMPA) Receptors. Journal of Medicinal Chemistry. 43(23). 4354–4358. 62 indexed citations

Zarrinmayeh, Hamideh, Dennis M. Zimmerman, Buddy E. Cantrell, et al.. (1999). Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 9(5). 647–652. 82 indexed citations

Siegel, Miles G., Michael O. Chaney, Robert F. Bruns, et al.. (1999). Rapid parallel synthesis applied to the optimization of a series of potent nonpeptide neuropeptide Y-1 receptor antagonists. Tetrahedron. 55(39). 11619–11639. 11 indexed citations

10.

Thomas, James B., S. Wayne Mascarella, Jason P. Burgess, et al.. (1998). N-substituted octahydro-4a-(3-hydroxyphenyl)-10a-methyl-benzo[g]isoquinolines are opioid receptor pure antagonists. Bioorganic & Medicinal Chemistry Letters. 8(22). 3149–3152. 5 indexed citations

11.

Zimmerman, Dennis M., Buddy E. Cantrell, Edward C. Smith, et al.. (1998). Structure-activity relationships of a series of 1-substituted-4-methylbenzimidazole neuropeptide Y-1 receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 8(5). 473–476. 14 indexed citations

12.

Thomas, James B., Xiaoling Zheng, S. Wayne Mascarella, et al.. (1998). N-Substituted 9β-Methyl-5-(3-hydroxyphenyl)morphans Are Opioid Receptor Pure Antagonists. Journal of Medicinal Chemistry. 41(21). 4143–4149. 27 indexed citations

13.

Thomas, James B., S. Wayne Mascarella, Richard B. Rothman, et al.. (1998). Investigation of the N-Substituent Conformation Governing Potency and μ Receptor Subtype-Selectivity in (+)-(3R,4R)-Dimethyl-4-(3-hydroxyphenyl)- piperidine Opioid Antagonists. Journal of Medicinal Chemistry. 41(11). 1980–1990. 25 indexed citations

14.

Cantrell, Buddy E., Dennis M. Zimmerman, James A. Monn, et al.. (1996). Synthesis of a Series of Aryl Kainic Acid Analogs and Evaluation in Cells Stably Expressing the Kainate Receptor humGluR6. Journal of Medicinal Chemistry. 39(19). 3617–3624. 30 indexed citations

15.

Zimmerman, Dennis M., et al.. (1994). Discovery of a Potent, Peripherally Selective trans-3,4-Dimethyl-4-(3-hydroxyphenyl)piperidine Opioid Antagonist for the Treatment of Gastrointestinal Motility Disorders. Journal of Medicinal Chemistry. 37(15). 2262–2265. 100 indexed citations

16.

Mitch, Charles H., J. David Leander, Laurane G. Mendelsohn, et al.. (1993). 3,4-Dimethyl-4-(3-hydroxyphenyl)piperidines: opioid antagonists with potent anorectant activity. Journal of Medicinal Chemistry. 36(20). 2842–2850. 50 indexed citations

17.

Zimmerman, Dennis M., J. David Leander, Buddy E. Cantrell, et al.. (1993). Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for .mu.- and .kappa.-opioid receptors. Journal of Medicinal Chemistry. 36(20). 2833–2841. 52 indexed citations

18.

Mitch, Charles H., et al.. (1991). Synthesis and absolute configuration of LY255582, a potent opioid antagonist. The Journal of Organic Chemistry. 56(4). 1660–1663. 17 indexed citations

19.

Zimmerman, Dennis M., Buddy E. Cantrell, J. K. SWARTZENDRUBER, et al.. (1988). Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolines. Journal of Medicinal Chemistry. 31(3). 555–560. 13 indexed citations

20.

Hynes, Martin D., et al.. (1987). Picenadol — a novel mixed agonist-antagonist analgesic with selective opioid receptor actions. Pain. 30. S151–S151.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact